All In Biotech

Drug Trial Radar · NCT05442190

Topical SGX302 for Mild-to-Moderate Psoriasis

Phase 2 Study Evaluating SGX302 (Synthetic Hypericin) in the Treatment of Mild-to-Moderate Psoriasis

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

15

Actual

Start

Dec 14, 2022

Primary completion

Oct 22, 2025

Study completion Nov 17, 2025

Sponsor

Lead sponsor
SoligenixIndustry
Sponsor type
Industry
First posted
Jul 1, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate SGX302 (topical hypericin ointment and gel) with visible light in an initial 18-week treatment course for improving lesions in patients with mild-to-moderate psoriasis.

Conditions

  • Psoriasis
  • Plaque Psoriasis
  • Psoriasis Vulgaris

Interventions

  • HypericinDrug

    SGX302 is synthetic hypericin formulated as a 0.25% hypericin ointment or gel.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Patients That Achieve a 0 or 1 Score Using the 5-point Investigator's Global Assessment ScaleTime frame: 18 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Therapeutics Clinical Research

    San Diego, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.